Administration of glucocorticoids (GCs) to women at risk of preterm delivery reduces the newborn’s risk of respiratory distress syndrome (RDS) by 35% to 40%; however, not all infants respond to this treatment. Fetal growth restriction (FGR) increases the risk of prematurity, perinatal morbidity, and mortality. This review aims to synthesize current evidence reporting the difference in RDS risk between FGR and normally grown infants (Question 1) and whether antenatal GC administration reduces the risk of RDS morbidity in FGR infants (Question 2). Systematic searches were performed, and after screening, a total of 27 and 9 citations were eligible for inclusion for Questions 1 and 2, respectively. In order to answer the two questions, odds ratios and 95% confidence intervals were calculated for all studies. The evidence was equivocal for a difference in risk of RDS in FGR compared with normally grown infants. Despite antenatal GC administration, there was evidence suggesting that the risk of RDS persists in FGR infants. The range of risk of RDS morbidity observed between studies is likely influenced by the definitions (RDS and FGR), gestational age, and small sample sizes of FGR infants evaluated. In addition, RDS morbidity may be related to the heterogeneous nature of FGR etiologies (including maternal, placental, and/or fetal factors). Further understanding of RDS morbidity and responsiveness to current treatments in FGR infants at a range of gestational ages, larger sample sizes, and stratification according to the specific etiology of FGR, may lead to improved respiratory outcomes at birth in this obstetric subpopulation.
BeckSWojdylaDSayL. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ. 2010;88(1):31–38.
2.
HilderLZhichaoZParkerMJahanSChambersG.Australia’s Mothers and Babies 2012. Canberra, Australia: Australian Institute of Health and Welfare; 2014.
3.
KamathBDMacGuireERMcClureEMGoldenbergRLJobeAH. Neonatal mortality from respiratory distress syndrome: lessons for low-resource countries. Pediatrics. 2011;127(6):1139–1146.
4.
AveryMEMeadJ. Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child. 1959;97(5 pt 1):517–523.
5.
LigginsGHowieR. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972;50(4):515–525.
6.
CrowleyPA. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol. 1995;173(1):322–335.
7.
CrowtherCAHaslamRRHillerJEDoyleLWRobinsonJS, Group ACToRDoSS. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet. 2006;367(9526):1913–1919.
8.
RobertsDDalzielS. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth (Review). Cochrane Database Syst Rev. 2006;(3):CD004454.
9.
MurphyKAghajafariF. Single versus repetitive courses of corticosteroids: what do we know?Clin Obstet Gynecol. 2003;46(1):161–173.
10.
BrownfootFCGagliardiDIBainEMiddletonPCrowtherCA. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2013;(8):CD006764.
11.
Gyamfi-BannermanCThomEABlackwellSC. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med. 2016;374(14):1311–1320.
12.
ElimianAVermaUCanterinoJShahJVisintainerPTejaniN. Effectiveness of antenatal steroids in obstetric subgroups. Obstet Gynecol. 1999;93(2):174–179.
13.
ShahSKaulA. Maternal corticosteroid use: effects on the fetus and neonate. Exp Rev Obstet Gynecol. 2013;8(6):569–579.
14.
Antenatal Corticosteroid Clinical Practice Guidelines Panel. Antenatal Corticosteroids Given to Women Prior to Birth to Improve Fetal, Infant, Child and Adult Health: Clinical Practice Guidelines. Auckland, New Zealand: Liggins Institute, The University of Auckland; 2015.
15.
LawsPSullivanEA. Australia’s mothers and babies 2007. Perinat Stat Series. 2009;(23):iii–115.
16.
RosenbergA. The IUGR newborn. Semin Perinatol. 2008;32(3):219–224.
17.
MorrisonJL. Sheep models of intrauterine growth restriction: fetal adaptations and consequences. Clin Exp Pharmacol Physiol. 2008;35(7):730–743.
18.
CrockerIP. Placental origins of intrauterine growth restriction. In: KayHHNelsonDMWangY, eds. The Placenta: From Development to Disease; 2011:237–245.
19.
HendrixNBerghellaV. Non-placental causes of intrauterine growth restriction. Semin Perinatol. 2008;32(3):161–165.
20.
MaritzGCockMLoueySJoyceBAlbuquerqueCHardingR. Effects of fetal growth restriction on lung development before and after birth: a morphometric analysis. Pediatr Pulmonol. 2001;32(3):201–210.
21.
GagnonRLangridgeJInchleyKMurotsukiJPossmayerF. Changes in surfactant-associated protein mRNA profile in growth-restricted fetal sheep. Am J Physiol Lung Cell Mol Physiol. 1999;276(3):L459–L465.
22.
CockMLAlbuquerqueCAJoyceBJHooperSBHardingR. Effects of intrauterine growth restriction on lung liquid dynamics and lung development in fetal sheep. Am J Obstet Gynecol. 2001;184(2):209–216.
23.
OrgeigSCrittendenTAMarchantCMcMillenICMorrisonJL. Intrauterine growth restriction delays surfactant protein maturation in the sheep fetus. Am J Physiol Lung Cell Mol Physiol. 2010;298(4): L575–583.
24.
SutherlandAECrossleyKJAllisonBJJenkinGWallaceEMMillerSL. The effects of intrauterine growth restriction and antenatal glucocorticoids on ovine fetal lung development. Pediatr Res. 2012;71(6):689–696.
25.
BernsteinIMHorbarJDBadgerGJOhlssonAGolanA. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. Am J Obstet Gynecol. 2000;182(1):198–206.
26.
GilbertWMDanielsenB. Pregnancy outcomes associated with intrauterine growth restriction. Am J Obstet Gynecol. 2003;188(6):1596–1601.
27.
McIntireDDBloomSLCaseyBMLevenoKJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med. 1999;340(16):1234–1238.
28.
PiperJMXenakisEMJMcFarlandMElliottBDBerkusMDLangerO. Do growth-retarded premature infants have different rates of perinatal morbidity and mortality than appropriately grown premature infants?Obstet Gynecol. 1996;87(2):169–174.
29.
QiuXLodhaAShahPS. Neonatal outcomes of small for gestational age preterm infants in Canada. Am J Perinatol. 2012;29(2):87–94.
30.
TysonJEKennedyKBroylesSRosenfeldCR. The small for gestational age infant: accelerated or delayed pulmonary maturation? Increased or decreased survival?Pediatrics. 1995;95(4):534–538.
31.
TorranceHLDerksJBScherjonSAWijnbergerLDVisserGHA. Is antenatal steroid treatment effective in preterm IUGR fetuses?Acta Obstet Gynecol Scand. 2009;88(10):1068–1073.
32.
LeyDWide-SwenssonDLindrothMSvenningsenNMarsalK. Respiratory distress syndrome in infants with impaired intrauterine growth. Acta Paediatr. 1997;86(10):1090–1096.
33.
BardinCZelkowitzPPapageorgiouA. Outcome of small-for-gestational age and appropriate-for-gestational age infants born before 27 weeks of gestation. Pediatrics. 1997;100(2):e4.
34.
SharmaPMcKayKRosenkrantzTHussainN. Comparisons of mortality and pre-discharge respiratory outcomes in small-for-gestational-age and appropriate-for-gestational-age premature infants. BMC Pediatr. 2004;4(1):9.
35.
BartelsDKreienbrockLDammannOWenzlaffPPoetsC. Population based study on the outcome of small for gestational age newborns. Arch Dis Child Fetal Neonatal Ed. 2005;90(1):F53–F59.
36.
ClaasMBruinseHVan der Heide-JalvingMTermoteJDe VriesL. Changes in survival and neonatal morbidity in infants with a birth weight of 750 g or less. Neonatology. 2009;98(3):278–288.
37.
BraemsGAYaoLJInchleyK. Ovine surfactant protein cDNAs: use in studies on fetal lung growth and maturation after prolonged hypoxemia. Am J Physiol Lung Cell Mol Physiol. 2000;278(4):L754–L764.
38.
MaritzGSCockMLLoueySSuzukiKHardingR. Fetal growth restriction has long-term effects on postnatal lung structure in sheep. Pediatr Res. 2004;55(2):287–295.
39.
MorrisonJLBottingKJSooPS. Antenatal steroids and the IUGR fetus: are exposure and physiological effects on the lung and cardiovascular system the same as in normally grown fetuses?J Pregnancy. 2012;2012:839656.
40.
MorrisonJLOrgeigS. Review: antenatal glucocorticoid treatment of the growth-restricted fetus: benefit or cost?Reprod Sci. 2009;16(6):527–538.
41.
BrianaDDMalamitsi-PuchnerA. Small for gestational age birth weight: impact on lung structure and function. Paediatr Respir Rev. 2013;14(4):256–262.
MitsiakosGKovacsLPapageorgiouA. Are antenatal steroids beneficial to severely growth restricted fetuses?J Matern Fetal Neonatal Med. 2013;26(15):1496–1499.
44.
TorranceHLMulderEJHBrouwersHAAvan BelFVisserGHA. Respiratory outcome in preterm small for gestational age fetuses with or without abnormal umbilical artery Doppler and/or maternal hypertension. J Matern Fetal Neonatal Med. 2007;20(8):613–621.
45.
DalzielSRReaHHWalkerNK. Long term effects of antenatal betamethasone on lung function: 30 year follow up of a randomised controlled trial. Thorax. 2006;61(8):678–683.
46.
OrgeigSMorrisonJL. Does the intrauterine growth-restricted fetus benefit from antenatal glucocorticoids?Expert Review Obstet Gynecol. 2010;5(2):149–152.
47.
MeneguelJFGuinsburgRMiyoshiMH. Antenatal treatment with corticosteroids for preterm neonates: impact on the incidence of respiratory distress syndrome and intra-hospital mortality. Sao Paulo Med J. 2003;121(2):45–52.
48.
ProcianoyRSGarcia-PratsJAAdamsJSilversARudolphA. Hyaline membrane disease and intraventricular haemorrhage in small for gestational age infants. Arch Dis Child. 1980;55(7):502–505.
49.
LaurinJPerssonP-HPolbergerS. Perinatal outcome in growth retarded pregnancies dated by ultrasound. Acta Obstet Gynecol Scand. 1987;66(4):337–343.
50.
Ruys-Dudok van HeelIde LeeuwR. Clinical outcome of small for gestational age preterm infants. J Perinat Med. 1989;17(2):77–83.
51.
ThompsonPGreenoughAGamsuHNicolaidesK. Ventilatory requirements for respiratory distress syndrome in small-for-gestational-age infants. Eur J Pediatr. 1992;151(7):528–531.
52.
GortnerLWauerRRStockGJ. Neonatal outcome in small for gestational age infants: do they really better?J Perinat Med. 1999;27(6):484–489.
53.
HoJ. Mortality and morbidity of the small for gestational age (SGA) very low birth weight (VLBW) Malaysian infant. Singapore Med J. 2001;42(8):355–359.
54.
ReissILandmannEHeckmannMMisselwitzBGortnerL. Increased risk of bronchopulmonary dysplasia and increased mortality in very preterm infants being small for gestational age. Arch Gynecol Obstet. 2003;269(1):40–44.
55.
RegevRHLuskyADolfinTLitmanovitzIArnonSReichmanB. Excess mortality and morbidity among small-for-gestational-age premature infants: a population-based study. J Pediatr. 2003;143(2):186–191.
56.
ZawWGagnonRda SilvaO. The risks of adverse neonatal outcome among preterm small for gestational age infants according to neonatal versus fetal growth standards. Pediatrics. 2003;111(6):1273–1277.
57.
EngineerNKumarS. Perinatal variables and neonatal outcomes in severely growth restricted preterm fetuses. Acta Obstet Gynecol Scand. 2010;89(9):1174–1181.
58.
YuHJKimESKimJK. Outcomes of small for gestational age micropremies depending on how young or how small they are. Korean J Pediatr. 2011;54(6):246–252.
GiaprosVDrougiaAKrallisNTheocharisPAndronikouS. Morbidity and mortality patterns in small-for-gestational age infants born preterm. J Matern Fetal Neonatal Med. 2012;25(2):153–157.
61.
ManzanaresSSanchez-GilaMMoreno-MartinezMDRamirez-ArredondoAPinedaA. Perinatal outcomes in preterm growth-restricted twins: effects of gestational age and fetal condition. Twin Res Hum Genet. 2013;16(03):727–731.
62.
De JesusLCPappasAShankaranS. Outcomes of small for gestational age infants born at <27 weeks’ gestation. J Pediatr. 2013;163(1):55–60.
63.
TsaiL-YChenY-LTsouK-IMuS-C, Group TPIDCS. The impact of small for gestational age on neonatal outcome among very low birth weight infants. Pediatr Neonatol. 2014;56(2):101–107.
64.
SpinilloACapuzzoEEgbeTFazziEColonnaLNicolaS. Pregnancies complicated by idiopathic intrauterine growth retardation. Severity of growth failure, neonatal morbidity and two-year infant neurodevelopmental outcome. J Reprod Med. 1995;40(3):209–215.
65.
SchaapAHWolfHBruinseHWHaasHSDEVan ErtbruggenITreffersPE. Effects of antenatal corticosteroid administration on mortality and long-term morbidity in early preterm, growth-restricted infants. Obstet Gynecol. 2001;97(6):954–960.
66.
van StralenGvan der BosJLoprioreE. No short-term benefits of antenatal corticosteroid treatment in severely preterm growth restricted fetuses: a case–control study. Early Hum Dev. 2009;85(4):253–257.
67.
IshikawaHMiyazakiKIkedaT. The effects of antenatal corticosteroids on short- and long-term outcomes in small-for-gestational-age infants. Int J Med Sci. 2015;12(4):295–300.
68.
LiuJCaoH-YWangH-WKongX-Y. The role of lung ultrasound in diagnosis of respiratory distress syndrome in newborn infants. Iran J Pediatr. 2014;24(2):147–154.
69.
Grisaru-GranovskySReichmanBLerner-GevaL. Mortality and morbidity in preterm small-for-gestational-age infants: a population-based study. Am J Obstet Gynecol. 2012;206(2):150. e151-e15-7.
70.
DamodaramMStoryLKulinskayaERutherfordMKumarS. Early adverse perinatal complications in preterm growth-restricted fetuses. Aust N Z J Obstet Gynaecol. 2011;51(3):204–209.
71.
KhashuMNarayananMBhargavaSOsiovichH. Perinatal outcomes associated with preterm birth at 33 to 36 weeks’ gestation: a population-based cohort study. Pediatrics. 2009;123(1):109–113.
72.
BotetFFiguerasJCarbonell-EstranyXArcaG, Group CS. Effect of maternal clinical chorioamnionitis on neonatal morbidity in very-low birthweight infants: a case-control study. J Perinat Med. 2010;38(3):269–273.
73.
MuSCLinCHChenYL. Impact on neonatal outcome and anthropometric growth in very low birth weight infants with histological chorioamnionitis. J Formos Med Assoc. 2008;107(4):304–310.
74.
KeyesLEArmazaFJNiermeyerSVargasEYoungDAMooreLG. Intrauterine growth restriction, preeclampsia, and intrauterine mortality at high altitude in Bolivia. Pediatr Res. 2003;54(1):20–25.
75.
TorranceHLVoorbijHWijnbergerLDvan BelFVisserGHA. Lung maturation in small for gestational age fetuses from pregnancies complicated by placental insufficiency or maternal hypertension. Early Hum Dev. 2008;84(7):465–469.
76.
PiazzeJJAnceschiMMPiconeGCerekjaALa TorreRCosmiEV. Association between maternal-fetal Doppler velocimetry and fetal lung maturity. J Perinat Med. 2003;31(6):484–488.
77.
ElsmenEPuppIHHellström-WestasL. Preterm male infants need more initial respiratory and circulatory support than female infants. Acta Paediatr. 2004;93(4):529–533.
78.
PapageorgiouANColleEFarri-KostopoulosEGelfandMM. Incidence of respiratory distress syndrome following antenatal betamethasone: role of sex, type of delivery, and prolonged rupture of membranes. Pediatrics. 1981;67(5):614–617.
79.
YinonYMazkerethRRosentzweigNJarus-HakakASchiffESimchenMJ. Growth restriction as a determinant of outcome in preterm discordant twins. Obstet Gynecol. 2005;105(1):80–84.
80.
WernerEFSavitzDAJanevicTM. Mode of delivery and neonatal outcomes in preterm, small-for-gestational-age newborns. Obstet Gynecol. 2012;120(3):560–564.
81.
HessolNAFuentes-AfflickE. Ethnic differences in neonatal and postneonatal mortality. Pediatrics. 2005;115(1):e44–e51.
82.
ThomasPPeabodyJTurnierVClarkRH. A new look at intrauterine growth and the impact of race, altitude, and gender. Pediatrics. 2000;106(2):e21.
83.
KavvadiaVGreenoughADimitriouGHooperR. Influence of ethnic origin on respiratory distress syndrome in very premature infants. Arch Dis Child Fetal Neonatal Ed. 1998;78(1):F25–F28.
84.
GariteTJClarkRThorpJA. Intrauterine growth restriction increases morbidity and mortality among premature neonates. Am J Obstet Gynecol. 2004;191(2):481–487.
Quist-ThersonEMyhrTOhlssonA. Antenatal steroids to prevent respiratory distress syndrome, multiple gestation as an effect modifier. Acta Obstet Gynecol Scand. 1999;78(5):388–392.
87.
HaasDMLehmannASSkaarT. The impact of drug metabolizing enzyme polymorphisms on outcomes after antenatal corticosteroid use. Am J Obstet Gynecol. 2012;206(5):447. e424-e447.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
